Edition:
United Kingdom

GlaxoSmithKline Consumer Healthcare Ltd (GLSM.NS)

GLSM.NS on National Stock Exchange of India

6,017.85INR
22 Jun 2018
Change (% chg)

Rs-30.25 (-0.50%)
Prev Close
Rs6,048.10
Open
Rs6,000.10
Day's High
Rs6,060.00
Day's Low
Rs5,975.00
Volume
4,767
Avg. Vol
20,770
52-wk High
Rs6,940.25
52-wk Low
Rs4,851.00

Select another date:

Tue, Mar 27 2018

Photo

GSK buys out Novartis in $13 billion consumer healthcare shake-up

FRANKFURT/ZURICH GlaxoSmithKline is buying Novartis out of their consumer healthcare joint venture for $13 billion (9 billion pounds), taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches. | Video

GSK buys out Novartis in $13 billion consumer healthcare shake-up

FRANKFURT/ZURICH GlaxoSmithKline is buying Novartis out of their consumer healthcare joint venture for $13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches. | Video

UPDATE 4-GSK buys out Novartis in $13 bln consumer healthcare shake-up

* Deal unravels JV agreed in 2014 (Adds fund manager quote, background on new Novartis CEO)

BRIEF-India's GlaxoSmithKline Consumer Healthcare Dec Qtr Profit Up 20 Pct

* DEC QUARTER PROFIT 1.64 BILLION RUPEES VERSUS PROFIT OF 1.36 BILLION RUPEES LAST YEAR

BRIEF-Neurometrix, Glaxosmithkline Announce Collaboration To Develop Quell Wearable Pain Relief Technology

* NEUROMETRIX AND GLAXOSMITHKLINE CONSUMER HEALTHCARE ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP AND EXPAND ACCESS TO QUELL WEARABLE PAIN RELIEF TECHNOLOGY

Select another date: